80005-113 : Etravirine 200 mg Oral Tablet


NDC: 80005-113
Labeler: Carnegie Pharmaceuticals LLC
Product Type: Human Prescription Drug
Drug Name:  Etravirine
Dosage Form: Oral Tablet
Application #: ANDA215402
Rev. Date: 


NDC Package Codes:

  • 80005-113-09: 60 TABLET IN 1 BOTTLE (80005‑113‑09)

Active Ingredients:

  • Etravirine

Dosage Strength:

  • 200 mg

Pharmaceutical Classes:

  • Cytochrome P450 2C19 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inhibitors [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Non-Nucleoside Analog [EXT]
  • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 80005-112 Etravirine 100 mg Oral Tablet by Carnegie Pharmaceuticals LLC
  • 42291-473 Etravirine 100 mg Oral Tablet by Avkare
  • 42291-474 Etravirine 200 mg Oral Tablet by Avkare
  • 60219-1720 Etravirine 25 mg Oral Tablet by Amneal Pharmaceuticals Ny LLC
  • 60219-1721 Etravirine 100 mg Oral Tablet by Amneal Pharmaceuticals Ny LLC
  • 60219-1722 Etravirine 200 mg Oral Tablet by Amneal Pharmaceuticals Ny LLC
  • 69238-1720 Etravirine 25 mg Oral Tablet by Amneal Pharmaceuticals Ny LLC
  • 69238-1721 Etravirine 100 mg Oral Tablet by Amneal Pharmaceuticals Ny LLC
  • 69238-1722 Etravirine 200 mg Oral Tablet by Amneal Pharmaceuticals Ny LLC
  • 69315-285 Etravirine 100 mg Oral Tablet by Leading Pharma, LLC
  • 69315-286 Etravirine 200 mg Oral Tablet by Leading Pharma, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 80005-113 QR Code

< Prev: 80005-112Next: 80005-119 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.